Roche's Xolair gets US nod for nasal polyps treatment
IgE blocker approved as an add-on treatment for adult patients
2nd December 2020
IgE blocker approved as an add-on treatment for adult patients
2nd December 2020
Agreement will aim to develop a platform to support radiologists' decision-making
2nd December 2020
First doses for emergency use will be delivered 'immediately'
2nd December 2020
Grünenthal will pay $320m upfront for the rights
1st December 2020
Follows on from success of the inaugural Patient Partnership Index Conference
1st December 2020
Research conducted at Oxford University used new scanning method
1st December 2020
Companies will aim to advance drug discovery for synucleinopathies
1st December 2020
Commonly used anti-inflammatory drug added to list of potential treatments
30th November 2020
Survey included input from scientists at The Institute of Cancer Research, London
30th November 2020
First biologic to be approved for children aged six to 11 years with condition
30th November 2020
New agreement takes supply up to seven million doses in total
30th November 2020
The combination is the first available to treat the underlying cause of CF in this patient group.
27th November 2020
Tepotinib could be the first treatment on the market for NSCLC in adults harbouring METex14 skipping alterations
27th November 2020
Trial results and cost-effectiveness are too uncertain for NHS use, the Institute said
27th November 2020
It is hoped that the test will help detect cancer at a much earlier stage
27th November 2020